Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS
· Delayed Price · Currency is USD
2.271
-0.029 (-1.27%)
Jul 3, 2025, 12:44 PM EDT
Medexus Pharmaceuticals Employees
Medexus Pharmaceuticals had 82 employees as of March 31, 2024. The number of employees decreased by 16 or -16.33% compared to the previous year.
Employees
82
Change (1Y)
-16
Growth (1Y)
-16.33%
Revenue / Employee
$1,190,462
Profits / Employee
$24,692
Market Cap
73.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Elite Pharmaceuticals | 64 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| Silence Therapeutics | 116 |
Medexus Pharmaceuticals News
- 8 days ago - Medexus Pharmaceuticals Inc. (MEDXF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Medexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States - Newsfile Corp
- 17 days ago - Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2025 Conference Call - Newsfile Corp
- 2 months ago - Medexus Successfully Completes Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in Quebec, Canada - Newsfile Corp
- 3 months ago - Medexus Provides Update on Progress of Commercialization of GRAFAPEX (treosulfan) for Injection - Newsfile Corp
- 4 months ago - Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp. - Newsfile Corp
- 4 months ago - Medexus Announces Commercial Availability of GRAFAPEX (treosulfan) for Injection - Newsfile Corp
- 5 months ago - Medexus Pharmaceuticals, Inc. (MEDXF) Q3 2025 Earnings Call Transcript - Seeking Alpha